The antibody market is projected to grow from USD 288.4 billion in 2025 to USD 628.5 billion by 2035, at a CAGR of 8.1%. Cancer will dominate with a 36.8% market share, while monoclonal antibodies will lead the product type segment with a 58.4% share.